Navigation

aluminum hydroxide/magnesium hydroxide/simethicone (Mylanta, Mygel, DiGel, Gelusil, Rulox)

 

Classes: Antacids, Combos

Dosing and uses of Mylanta, Mygel (aluminum-hydroxide-magnesium-hydroxide-simethicone)

 

Adult dosage forms and strengths

aluminum hydroxide/magnesium hydroxide/simethicone

liquid

  • (200mg/200mg/20mg)/5mL
  • (400mg/400mg/40mg)/5mL

suspension

  • (225mg/200mg/25mg)/5mL

tablet, chewable

  • 200mg/200mg/25mg (Gelusil)

 

Dyspepsia, Abdominal Bloating

10-20 mL PO q4-6hr taken 1 hour before or 3 hours after meals, Or

Chew 2-4 tablets q4-6hr; not to exceed 12 tablets/24 hr

 

Pediatric dosage forms and strengths

Safety & efficacy not established

 

Mylanta, Mygel (aluminum-hydroxide-magnesium-hydroxide-simethicone) adverse (side) effects

Frequency not defined

Aluminum hydroxide

  • Chalky taste
  • Constipation
  • Fecal impaction
  • Stomach cramps
  • Nausea
  • Vomiting
  • Rebound hyperacidity
  • Aluminum intoxication
  • Hypophosphatemia
  • Milk-alkali syndrome
  • Osteomalacia

Magnesium hydroxide

  • Diarrhea
  • Hypermagnesemia

Simethicone

  • Loose stools

 

Warnings

Contraindications

Hypersensitivity to any component of the formulation

 

Cautions

Caution in renal failure

May increase or decrease rate &/or degree of absorption of concomitantly administered oral drugs by changing GI transit time or by binding the drug

Mg-restricted diet

Similar Trade Names may have different compositions

Do not use combination product for hyperphosphatemia

 

Pregnancy and lactation

Pregnancy category: C

Lactation: excretion in milk unknown

 

Pregnancy categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

 

Pharmacology of Mylanta, Mygel (aluminum-hydroxide-magnesium-hydroxide-simethicone)

Mechanism of action

Aluminum hydroxide: Neutralizes stomach hydrocloride to form AlCl3 salt plus water; increases gastric pH

Magnesium hydroxide: Promotes bowel evacuation by causing osmotic retention of fluid, which causes the colon to distend with increased peristaltic activity; forms magnesium chloride when reacts with hydrochloric acid

Simethicone: Disperses and prevents gas pockets in the GI system by decreasing surface tension of gas bubles

 

Elimination

Excretion

  • Aluminium hydroxide: Absorbed Al ions are eliminated in the urine (0.1-0.5 mg of Al in aluminum-containing antacid is absorbed from standard daily doses of antacid), Insoluble or poorly absorbed Al salts in the intestines are excreted in feces
  • Magnesium hydroxide: absorbed Mg ions (up to 30%) are eliminated in urine, unabsorbed drug is excreted in feces